On June 28, 2019, during the Chinese Oncology Conference, the Professional Committee of the Oncology Branch of the Chinese Medical Association was established and held academic activities. At the same time, the "multi-center clinical trial" project carried out by Tianjin Medical University Cancer  Institute & Hospital and many domestic hospitals was successfully held during this meeting. Professor Zheng Xiangqian from Tianjin Medical University Cancer  Institute & Hospital , Professor Guan Haixia from the First Hospital of China Medical University, Professor Liu Zhiyan from the Department of Pathology, Qilu Hospital of Shandong University, and Professor Shao Jianyong from the Sun Yat-sen University Cancer center jointly discuss the progress and propose new ideas.

Shanghai Ruijing Biotechnology Co., Ltd. is committed to individualized medical treatment of tumors and participated in the multi-center clinical project research throughout.

The academic feast was held, which attracted many media's follow-up reports.